Media & Resources

Seeking Novel Protein Design to Help Solve the Neutralizing Antibody Problem Mass. General, MIT WALTHAM, MA, Dec 17, 2008 — InnoCentive, Inc., the global innovation marketplace, today announced that the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use…

Testimonials to Help Raise Global Support for AIDS Vaccine Development New York, December 1, 2008—On the 20th anniversary of World AIDS Day, the International AIDS Vaccine Initiative (IAVI) invites individuals from around the world to show their support for the development of an AIDS vaccine by contributing their voices to a new gallery of video…

London, 27 November 2008 –  The International AIDS Vaccine Initiative (IAVI) and the St. Stephen’s AIDS Trust at the Chelsea and Westminster Hospital have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates. “Prevention is crucial in the fight against HIV and AIDS, and a…

The St. Stephen’s Centre at the Chelsea and Westminster Hospital in London is preparing for the start of a new trial to test an HIV vaccine candidate.  The trial is anticipated to provide important information on the ability of the vaccine to stimulate an immune response that may be able to protect against HIV infection…

On Nov. 26, the Lancet published a paper by Reuben Granich et al exploring through a mathematical model the theoretical effect on the AIDS epidemic of an intensive program of HIV testing and treatment. The authors explored what might happen in a community if every individual above the age of 15 voluntarily received an HIV…

THE INTERNATIONAL AIDS VACCINE INITIATIVE OPENS STATE-OF-THE-ART LABORATORY IN PLANNED NEW BIOSCIENCE CENTER IN NEW YORK CITY NEW YORK, November 12, 2008 — Today New York City Mayor Michael R. Bloomberg honored the International AIDS Vaccine Initiative (IAVI) at a ribbon-cutting ceremony for its new AIDS Vaccine Design and Development Laboratory—a 36,000 square foot, state-of-the-art…

Washington, DC — Around the world, at the end of 2007, there were an estimated 33.2 million people living with HIV/AIDS. 2 million of those living with HIV/AIDS were children, and 2.5 million were newly infected. More than 2 million people died of HIV/AIDS worldwide in 2007. Every day during that year 1,000 children became…

LONDON, 4 November 2008—The International AIDS Vaccine Initiative (IAVI) applauds the UK government for strengthening its support for research into new prevention technologies to fight HIV/AIDS. During a meeting of scientists and experts convened by the UK Department for International Development, International Development Minister Gareth Thomas announced that the UK government would contribute £220 million…